Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Apr 29;22(6):709–724. doi: 10.1002/ptr.2362

Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds

Marjan Nassiri Asl 1, Hossein Hosseinzadeh 1,✉
PMCID: PMC7167813  PMID: 18446848

Abstract

The roots and rhizomes of licorice (Glycyrrhiza) species have long been used worldwide as a herbal medicine and natural sweetener. Licorice root is a traditional medicine used mainly for the treatment of peptic ulcer, hepatitis C, and pulmonary and skin diseases, although clinical and experimental studies suggest that it has several other useful pharmacological properties such as antiinflammatory, antiviral, antimicrobial, antioxidative, anticancer activities, immunomodulatory, hepatoprotective and cardioprotective effects. A large number of components have been isolated from licorice, including triterpene saponins, flavonoids, isoflavonoids and chalcones, with glycyrrhizic acid normally being considered to be the main biologically active component. This review summarizes the phytochemical, pharmacological and pharmacokinetics data, together with the clinical and adverse effects of licorice and its bioactive components. Copyright © 2008 John Wiley & Sons, Ltd.

Keywords: licorice, Glycyrrhiza glabra, glycyrrhizin, glabridin, glycyrrhitinic acid, isoliquiritigenin

REFERENCES

  1. Abe N, Ebina T, Ishida N. 1982. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Immunol 26: 535–559. [DOI] [PubMed] [Google Scholar]
  2. Adamyan TsI, Gevorkyan ES, Minasyan SM, Oganesyan KR, Kirakosyan KA. 2005. Effect of licorice root on peripheral blood indexes upon vibration exposure. Bull Exp Biol Med 140: 197–200. [DOI] [PubMed] [Google Scholar]
  3. Afreen F, Zobayed SMA, Kozai T. 2005. Spectral quality and UV‐B stress stimulate glycyrrhizin concentration of Glycyrrhiza uralensis in hydroponic and pot system. Plant Physiol Biochem 43: 1074–1081. [DOI] [PubMed] [Google Scholar]
  4. Akamatsu H, Komura J, Asada Y, Niwa Y. 1991. Mechanism of anti‐inflammatory action of glycyrrhizin: effects on neutrophil functions including reactive oxygen species generation. Planta Med 57: 119–121. [DOI] [PubMed] [Google Scholar]
  5. Akao T, Akao T, Hattori M et al. 1991. Hydrolysis of glycyrrhizin to 18 beta‐glycyrrhetyl monoglucuronide by lysosomal beta‐d‐glucuronidase of animal livers. Biochem Pharmacol 41: 1025–1029. [DOI] [PubMed] [Google Scholar]
  6. Aly AM, Al‐Alousi L, Salem HA. 2005. Licorice: A possible anti‐inflammatory and anti‐ulcer drug. AAPS Pharm Sci Tech 6: E74–E82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Amagaya S, Sugishita E, Ogihara Y, Ogawa S, Okada K, Aizawa T. 1984. Comparative studies of the stereoisomers of glycyrrhetinic acid on anti‐inflammatory activities. J Pharmacobiodyn 79: 923–928. [DOI] [PubMed] [Google Scholar]
  8. Amaryan G, Astvatsatryan V, Gabrielyan E, Panossian A, Panosyan V, Wikman G. 2003. Double‐blind, placebo‐controlled, randomized, pilot clinical trial of ImmunoGuard® – a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever. Phytomedicine 10: 271–285. [DOI] [PubMed] [Google Scholar]
  9. Ambawade SD, Kasture VS, Kasture SB. 2002. Anticonvulsant activity of roots and rhizomes of G. glabra. Ind J Pharmacol 34: 251–255. [Google Scholar]
  10. Amer M, Metwalli M. 2000. Topical liquiritin improves melasma. Int J Dermatol 39: 299–301. [DOI] [PubMed] [Google Scholar]
  11. Arase Y, Ikeda K, Murashima N et al. 1997. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79: 1494–1500. [DOI] [PubMed] [Google Scholar]
  12. Armanini D, Bonannia G, Mattarello MJ, Fiore C, Sartorato P, Palermo M. 2003. Licorice consumption and serum testosterone in healthy man. Exp Clin Endocrinol Diabetes 111: 341–343. [DOI] [PubMed] [Google Scholar]
  13. Armanini D, Bonanni G, Palermo M. 1999. Reduction of serum testosterone in men by licorice. N Engl J Med 341: 1158. [DOI] [PubMed] [Google Scholar]
  14. Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M. 2002. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes 110: 257–261. [DOI] [PubMed] [Google Scholar]
  15. Armanini D, Mattarello MJ, Fiore C et al. 2004. Licorice reduces serum testosterone in healthy women. Steroids 69: 763–766. [DOI] [PubMed] [Google Scholar]
  16. Armanini D, Nacamulli D, Francini‐Pesenti F, Battagin G, Ragazzi E, Fiore C. 2005. Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids 70: 538–542. [DOI] [PubMed] [Google Scholar]
  17. Arseculeratne SN, Gunatilaka AAL, Panabokke RG. 1985. Studies on medicinal plants of Srilanka. Part 14. Toxicity of medicinal herbs. J Ethnopharmacol 13: 323–335. [DOI] [PubMed] [Google Scholar]
  18. Asgary S, Madani H, Naderi GH, Toori SH, Taleb‐Alhoseini M. 2005. Hepatoprotective effect of Silybum marianum (L.) Gaertn. and Glycyrrhiza glabra L. in the rats. J Med Plants 4: 18–24. [Google Scholar]
  19. Azimov MM, Zakirov UB, Radzhapova ShD. 1988. Pharmacological study of the anti‐inflammatory agent glyderinine. Farmakol Toksikol 51: 90–93. [PubMed] [Google Scholar]
  20. Baba M, Asano R, Takigami I et al. 2002. Studies on cancer chemoprevention by traditional folk medicines, XXV. Inhibitory effect of isoliquiritigenin on azoxymethane‐induced murine colon aberrant crypt focus formation and carcinogenesis. Biol Pharm Bull 25: 247–250. [DOI] [PubMed] [Google Scholar]
  21. Baba M, Shigeta S. 1987. Antiviral activity of glycyrrhizin against varicella‐zoster virus in vitro . Antiviral Res 7: 99–107. [DOI] [PubMed] [Google Scholar]
  22. Baker ME. 1994. Licorice and enzymes other than 11 beta‐hydroxysteroid dehydrogenase: an evolutionary perspective. Steroids 59: 136–141. [DOI] [PubMed] [Google Scholar]
  23. Bannister B, Ginsburg R, Shneerson J. 1977. Cardiac arrest due to liquorice induced hypokalaemia. Br Med J 2: 738–739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Barfod L, Kemp K, Hansen M, Kharazmi A. 2002. Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines. Int Immunopharmacol 2: 545–555. [DOI] [PubMed] [Google Scholar]
  25. Belinky PA, Aviram M, Furhman B, Rosenblat M, Vaya J. 1998a. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 137: 49–61. [DOI] [PubMed] [Google Scholar]
  26. Belinky PA, Aviram M, Mahmood S, Vaya J. 1998b. Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radic Biol Med 24: 1419–1429. [DOI] [PubMed] [Google Scholar]
  27. Bernardi M, D′ Intino PE, Trevisani F et al. 1994. Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sci 55: 863–872. [DOI] [PubMed] [Google Scholar]
  28. Biondi DM, Rocco C, Ruberto G. 2005. Dihydrostilbene derivatives from Glycyrrhiza glabra leaves. J Nat Prod 68: 1099–1102. [DOI] [PubMed] [Google Scholar]
  29. Blumenthal M, Goldberg A, Brinckmann J. 2000. Herbal Medicine: Expanded Commission E Monographs. American Botanical Council: Newton, 233–236. [Google Scholar]
  30. Briganti S, Camera E, Picardo M. 2003. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16: 101–110. [DOI] [PubMed] [Google Scholar]
  31. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. 2000. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7: 273–282. [DOI] [PubMed] [Google Scholar]
  32. Cantelli‐Forti G, Maffei F, Hrelia P et al. 1994. Interaction of liquorice on glycyrrhizin pharmacokinetics. Environ Health Perspect 102 (Suppl 9): 65–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Capasso F, Mascolo N, Autore G, Duraccio MR. 1983. Glycyrrhetinic acid, leucocytes and prostaglandins. J Pharm Pharmacol 35: 332–335. [DOI] [PubMed] [Google Scholar]
  34. Carmines EL, Lemus R, Gaworski CL. 2005. Toxicologic evaluation of licorice extract as a cigarette ingredient. Food Chem Toxicol 43: 1303–1322. [DOI] [PubMed] [Google Scholar]
  35. Cassileth BR, Barazzuol JD. 2001. Herbal products and other supplements problems of special relevance to surgery. J Pelvic Surgery 7: 21–26. [Google Scholar]
  36. Chan H‐T, Chan C, Ho JW. 2003. Inhibition of glycyrrhizic acid on aflatoxin B1‐induced cytotoxicity in hepatoma cells. Toxicology 188: 211–217. [DOI] [PubMed] [Google Scholar]
  37. Chen M, Christensen SB, Blom J et al. 1993. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania . Antimicrob Agents Chemother 37: 2550–2556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chen M, Christensen SB, Theander TG, Kharazmi A. 1994a. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani . Antimicrob Agents Chemother 38: 1339–1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Chen MF, Shimada F, Kato H, Yano S, Kanaoka M. 1991. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. Endocrinol Jpn 38: 167–175. [DOI] [PubMed] [Google Scholar]
  40. Chen M, Theander TG, Christensen SB, Hviid L, Zhai L, Kharazmi A. 1994b. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother 38: 1470–1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Chen M, Zhai L, Christensen SB, Theander TG, Kharazmi A. 2001. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob Agents Chemother 45: 2023–2029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Choi EM. 2005. The licorice root derived isoflavan glabridin increases the function of osteoblastic MC3T3‐E1 cells. Biochem Pharmacol 70: 363–368. [DOI] [PubMed] [Google Scholar]
  43. Christensen SB, Kharazmi A. 2001. Antimalarial natural products In Bioactive Compounds from Natural Sources: Isolation, Characterization and Biological Properties, Tringali C. (ed.). Taylor and Francis Inc: New York, 404. [Google Scholar]
  44. Christensen SB, Ming C, Andersen L et al. 1994. An antileishmanial chalcone from Chinese licorice roots. Planta Med 60: 121–123. [DOI] [PubMed] [Google Scholar]
  45. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. 2003. Glycyrrhizin, an active component of liquorice roots, and replication of SARS‐associated coronavirus. Lancet 361: 2045–2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Cohen D, Heidary N. 2004. Treatment of irritant and allergic contact dermatitis. Dermatol Ther 17: 334–340. [DOI] [PubMed] [Google Scholar]
  47. Cohen JI. 2005. Licking latency with licorice. J Clin Invest 115: 591–593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Conn JW, Rovner DR, Cohen EL. 1968. Licorice‐induced pseudoaldosteronism, hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity. JAMA 205: 492–496. [DOI] [PubMed] [Google Scholar]
  49. Craig WJ. 1999. Health‐promoting properties of common herbs. Am J Clin Nutr 70: 491S–499S. [DOI] [PubMed] [Google Scholar]
  50. Crance JM, Biziagos E, Passagot J, Van Cuyck‐Gandre H, Deloince R. 1990. Inhibition of hepatitis A virus replication in vitro by antiviral compounds. J Med Virol 31: 155–160. [DOI] [PubMed] [Google Scholar]
  51. Curreli F, Friedman‐Kien AE, Flore O. 2005. Glycyrrhizic acid alters Kaposi sarcoma‐associated herpesvirus latency, triggering p53‐mediated apoptosis in transformed B lymphocytes. J Clin Invest 115: 642–652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Dafni A, Yaniv Z, Palevitch D. 1984. Ethnobotanical survey of medicinal plants in northern Israel. J Ethnopharmacol 10: 295–310. [DOI] [PubMed] [Google Scholar]
  53. Davidson JS, Baumgarten IM. 1988. Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap‐junctional intercellular communication. Structure‐activity relationships. J Pharmacol Exp Ther 246: 1104–1107. [PubMed] [Google Scholar]
  54. De Groot G, Koops R, Hogendoorn EA, Goewie CE, Savelkaul TJF, Van Vloten P. 1988. Improvement of selectivity and sensitivity by column switching in the determination of glycyrrhizin and glycyrrhetic acid in human plasma by high‐performance liquid chromatography. J Chromatogr 456: 71–81. [DOI] [PubMed] [Google Scholar]
  55. De Klerk GJ, Nieuwenhuis MG, Beutle JJ. 1997. Hypokalaemia and hypertension associated with use of liquorice flavoured chewing gum. Br Med J 314: 731–732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. De Simone F, Aquino R, De Tommasi N, Mahmood N, Piacente S, Pizza C. 2001. Anti‐HIV aromatic compounds from higher plants In Bioactive Compounds from Natural Sources: Isolation, Characterization and Biological Properties, Tringali C. (ed.). Taylor and Francis: New York, 325. [Google Scholar]
  57. Dhingra D, Parle M, Kularni SK. 2004. Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 91: 361–365. [DOI] [PubMed] [Google Scholar]
  58. Dhingra D, Sharma D. 2006. Antidepressant‐like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Progress Neuro‐Psychopharmacol Bio Psychiat 30: 449–454. [DOI] [PubMed] [Google Scholar]
  59. Di Mambro VM, Fonseca MJV. 2005. Assays of physical stability and antioxidant activity of a topical formulation added with different plant extracts. J Pharm Biomed Anal 37: 287–295. [DOI] [PubMed] [Google Scholar]
  60. DiPaola RS, Zhang H, Lambert GH et al. 1998. Clinical and biologic activity of an estrogenic herbal combination (PC‐SPES) in prostate cancer. N Engl J Med 339: 785–791. [DOI] [PubMed] [Google Scholar]
  61. Dobbins KRB, Saul RF. 2000. Transient visual loss after licorice ingestion. J Neuro‐Ophthalmol 20: 38–41. [DOI] [PubMed] [Google Scholar]
  62. Eriiksson JW, Carlberg B, Hillorn V. 1999. Life‐threatening ventricular tachycardia due to liquorice‐induced hypokalemia. J Int Med 245: 307–310. [DOI] [PubMed] [Google Scholar]
  63. Fedotova YuO, Krauz VA, Papkovskaya AA. 2005. The effect of dry cleared extract from licorice roots on the learning of ovariectomized rats. Pharm Chem J 39: 422–424. [Google Scholar]
  64. Ferrari P, Sansonnens A, Dick B, Frey FJ. 2001. In vivo 11β‐HSD‐2 activity variability, salt‐sensitivity, and effect of licorice. Hypertension 38: 1330–1336. [DOI] [PubMed] [Google Scholar]
  65. Fiore C, Salvi M, Palermo M, Sinigagliab G, Armaninia D, Toninello A. 2004. On the mechanism of mitochondrial permeability transition induction by glycyrrhetinic acid. Biochim Biophys Acta 1658: 195–201. [DOI] [PubMed] [Google Scholar]
  66. Francischetti IM, Monteiro RQ, Guimaraes JA. 1997. Identification of glycyrrhizin as a thrombin inhibitor. Biochem Biophys Res Commun 235: 259–263. [DOI] [PubMed] [Google Scholar]
  67. Fraunfelder FW. 2004. Perspective ocular side effects from herbal medicines and nutritional supplements. Am J Ophthalmol 138: 639–647. [DOI] [PubMed] [Google Scholar]
  68. Fu Y, Hsieh TC, Guo J et al. 2004. Licochalcone‐A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late‐G1 arrests in androgen‐independent PC‐3 prostate cancer cells. Biochem Biophys Res Commun 322: 263–270. [DOI] [PubMed] [Google Scholar]
  69. Fu B, Li H, Wang X, Lee FSC, Cui S. 2005. Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase. J Agric Food Chem 53: 7408–7414. [DOI] [PubMed] [Google Scholar]
  70. Fugh‐Berman A, Ernst E. 2001. Herb–drug interactions: Review and assessment of report reliability. Br J Clin Pharmacol 52: 587–595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Fuhrman B, Buch S, Vaya J et al. 1997. Licorice extract and its major polyphenol glabridin protect low‐density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E‐deficient mice. Am J Clin Nutr 66: 276–275. [DOI] [PubMed] [Google Scholar]
  72. Fujita T, Sezik E, Tabata M, Yesilada E, Honda G, Takeda Y. 1995. Traditional medicine in Turkey VII. Folk medicine in middle and regions. Taan Econ Bot 49: 406–422. (From NAPRALERT) [Google Scholar]
  73. Fukai T, Cai B‐S, Maruno K, Miyakawa Y, Konishi M, Nomura T. 1998. An isoprenylated flavanone from Glycyrrhiza glabra and rec‐assay of licorice phenols. Phytochemistry 49: 2005–2013. [Google Scholar]
  74. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. 2002a. Anti‐Helicobacter pylori flavonoids from licorice extract. Life Sci 71: 1449–1463. [DOI] [PubMed] [Google Scholar]
  75. Fukai T, Marumo A, Kaitou K, Kanda T, Terada S, Nomura T. 2002b. Antimicrobial activity of licorice flavonoids against methicillin‐resistant Staphylococcus aureus. Fitoterapia 73: 536–539. [DOI] [PubMed] [Google Scholar]
  76. Fukai T, Satoh K, Nomura T, Sakagami T. 2003. Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra. Fitoterapia 74: 624–629. [DOI] [PubMed] [Google Scholar]
  77. Furuhashi I, Iwata S, Shibata S, Sato T, Inoue H. 2005. Inhibition by licochalcone A, a novel flavonoid isolated from liquorice root, of IL‐1β‐induced PGE2 production in human skin fibroblasts. J Pharm Pharmacol 57: 1661–1666. [DOI] [PubMed] [Google Scholar]
  78. Gareri P, Condorelli D, Belluardo D et al. 2004. Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology 47: 1205–1216. [DOI] [PubMed] [Google Scholar]
  79. Goldie MP. 2005. Antioxidants in oral health care: making the connection. Int J Dent Hygiene 3: 93–95. [DOI] [PubMed] [Google Scholar]
  80. Gray AM, Flatt PR. 1997. Nature's own pharmacy: The diabetes perspective. Proc Nutr Soc 56: 507–517. [DOI] [PubMed] [Google Scholar]
  81. Gross EG, Dexter JD, Roth RG. 1966. Hypokalemic myopathy with myoglobinuria associated with licorice ingestion. N Engl J Med 274: 602–606. [DOI] [PubMed] [Google Scholar]
  82. Gumpricht E, Dahl R, Devereaux MW, Sokol RJ. 2005. Licorice compounds glycyrrhizin and 18β‐glycyrrhetinic acid are potent modulators of bile acid‐induced cytotoxicity in rat hepatocytes. J Biol Chem 280: 10556–10563. [DOI] [PubMed] [Google Scholar]
  83. Halder RM, Richards GM. 2004. Topical agents used in the management of hyperpigmentation. Skin Ther Lett 9: 1–3. [PubMed] [Google Scholar]
  84. Haraguchi H. 2001. Antioxidative plant constituents In Bioactive Compounds from Natural Sources: Isolation, Characterization and Biological Properties, Tringali C. (ed.). Taylor and Francis: New York, 348–352. [Google Scholar]
  85. Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T. 1998. Antioxidative and superoxide scavenging activities of retrochalchones in Glycyrrhiza inflata . Bioorg Med Chem 6: 339–347. [DOI] [PubMed] [Google Scholar]
  86. Haraguchi H, Yoshida N, Ishikawa H, Tamura Y, Mizutani K, Kinoshita T. 2000. Protection of mitochondrial functions against oxidative stresses by isoflavans from Glycyrrhiza glabra . J Pharm Pharmacol 52: 219–223. [DOI] [PubMed] [Google Scholar]
  87. Hatano T, Aga Y, Shintani Y, Ito H, Okuda T, Yoshida T. 2000a. Minor flavonoids from licorice. Phytochemistry 55: 959–963. [DOI] [PubMed] [Google Scholar]
  88. Hatano T, Fukuda T, Liu YZ, Noro T, Okuda T. 1991a. Phenolic constituents of licorice. IV. Correlation of phenolic constituents and licorice specimens from various sources, and inhibitory effects of licorice extracts on xanthine oxidase and monoamine oxidase. Yakugaku Zasshi 111: 311–321. [DOI] [PubMed] [Google Scholar]
  89. Hatano T, Fukuda T, Miyase TT, Noro T, Okuda T. 1991b. Phenolic constituents of licorice. III. Structures of glicoricone and licofuranone, and inhibitory effects of licorice constituents on monoamine oxidase. Chem Pharm Bull 39: 1238–1243. [DOI] [PubMed] [Google Scholar]
  90. Hatano T, Kusuda M, Inada K et al. 2005. Effects of tannins and related polyphenols on methicillin‐resistant Staphylococcus aureus. Phytochemistry 66: 2047–2055. [DOI] [PubMed] [Google Scholar]
  91. Hatano T, Shintani Y, Aga Y, Shiota S, Tsuchiya T, Yoshida T. 2000b. Phenolic constituents of licorice. VIII. Structures of glicophenone and glicoisoflavanone, and effects of licorice phenolics on methicillin‐resistant Staphylococcus aureus . Chem Pharm Bull 48: 1286–1292. [DOI] [PubMed] [Google Scholar]
  92. Hatano T, Yasuhara T, Miyamoto K, Okuda T. 1988. Anti‐human immunodeficiency virus phenolics from licorice. Chem Pharm Bull 36: 2286–2288. [DOI] [PubMed] [Google Scholar]
  93. Hattori M, Sakamoto T, Yamagishi T et al. 1985. Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds. Chem Pharm Bull 33: 210–217. [DOI] [PubMed] [Google Scholar]
  94. Hayashi H, Hiraoka N, Ikeshiro Y, Yamamoto H, Yoshikawa T. 1998. Seasonal variation of glycyrrhizin and isoliquiritigenin glycosides in the root of Glycyrrhiza glabra L . Biol Pharm Bull 21: 987–989. [DOI] [PubMed] [Google Scholar]
  95. He J, Chen L, Heber D, Shi W, Lu Q‐Y. 2006. Antibacterial compounds from Glycyrrhiza uralensis . J Nat Prod 69: 121–124. [DOI] [PubMed] [Google Scholar]
  96. Hosseinzadeh H, Nassiri Asl M. 2003. Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC Pharmacol 3: 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Hosseinzadeh H, Nassiri Asl M, Parvardeh S. 2005a. The effects of carbenoxolone, a semisynthetic derivative of glycyrrhizinic acid, on peripheral and central ischemia‐reperfusion injuries in the skeletal muscle and hippocampus of rats. Phytomedicine 12: 632–637. [DOI] [PubMed] [Google Scholar]
  98. Hosseinzadeh H, Nassiri Asl M, Parvardeh S, Mansouri SMT. 2005b. The effects of carbenoxolone on spatial learning in the Morris water maze task in rats. Med Sci Mon 11: 88–94. [PubMed] [Google Scholar]
  99. Hou YC, Hsiu SL, Ching H et al. 2005. Profound difference of metabolic pharmacokinetics between pure glycyrrhizin and glycyrrhizin in liquorice decoction. Life Sci 76: 1167–1176. [DOI] [PubMed] [Google Scholar]
  100. Hsu YL, Kuo PL, Chiang LC, Lin CC. 2004. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non‐small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol 31: 414–418. [DOI] [PubMed] [Google Scholar]
  101. Hsu YL, Kuo PL, Lin LT, Lin CC. 2005. Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med 71: 130–134. [DOI] [PubMed] [Google Scholar]
  102. Hu WY, Li YW, Hou YN et al. 1999. The induction of liver microsomal cytochrome P450 by Glycyrrhiza uralensis and glycyrrhetinic acid in mice. Biomed Environ Sci 12: 10–14. [PubMed] [Google Scholar]
  103. Hult M, Jornvall H, Oppermann UCT. 1998. Selective inhibition of human type 1 11β‐hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics. FEBS Lett 441: 25–28. [DOI] [PubMed] [Google Scholar]
  104. Ii T, Satomi Y, Katoh D et al. 2004. Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin. Cancer Lett 207: 27–35. [DOI] [PubMed] [Google Scholar]
  105. Iino S, Tango T, Matsushima T et al. 2001. Therapeutic effects of stronger Neo‐Minophagen C at different doses on chronic hepatitis and liver cirrhosis. Hepatol Res 19: 31–40. [DOI] [PubMed] [Google Scholar]
  106. Inoue H, Mori T, Shibata S, Koshihara Y. 1989. Modulation by glycyrrhetinic acid derivatives of TPA‐induced mouse ear oedema. Br J Pharmacol 96: 204–210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Ishiwata S, Nakashita K, Ozawa Y et al. 1999. Fas‐mediated apoptosis is enhanced by glycyrrhizin without alteration of caspase‐3‐like activity. Biol Pharm Bull 22: 1163–1166. [DOI] [PubMed] [Google Scholar]
  108. Ito M, Sato A, Hirabayashi K et al. 1988. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res 10: 289–298. [DOI] [PubMed] [Google Scholar]
  109. Iwashita K, Kobori M, Yamaki K, Tsushida T. 2000. Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 64: 1813–1820. [DOI] [PubMed] [Google Scholar]
  110. Jackson KM, DeLeon M, Verret CR, Harris WB. 2002. Dibenzoylmethane induces cell cycle deregulation in human prostate cancer cells. Cancer Lett 178: 161–165. [DOI] [PubMed] [Google Scholar]
  111. Jellinck PH, Monder C, McEwen BS, Sakai RR. 1993. Differential inhibition of 11 beta‐hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J Steroid Biochem Mol Biol 46: 209–213. [DOI] [PubMed] [Google Scholar]
  112. Jenett‐Siems K, Mockenhaupt FP, Bienzle U, Gupta MP, Eich E. 1999. In vitro antiplasmodial activity of Central American medicinal plants. Trop Med Int Health 4: 611–615. [DOI] [PubMed] [Google Scholar]
  113. Jeong HG, Kim JY. 2002. Induction of inducible nitric oxide synthase expression by 18β‐glycyrrhetinic acid in macrophages. FEBS Lett 513: 208–212. [DOI] [PubMed] [Google Scholar]
  114. Jeong HG, You HJ, Park SJ et al. 2002. Hepatoprotective effects of 18β‐glycyrrhetinic acid on carbon tetrachloride‐induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharm Res 46: 221–227. [DOI] [PubMed] [Google Scholar]
  115. Jo E‐H, Kim S‐H, Ra JC et al. 2005. Chemopreventive properties of the ethanol extract of Chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF‐7 human breast cancer cells. Cancer Lett 230: 239–247. [DOI] [PubMed] [Google Scholar]
  116. Jong SK, Yeo DY, Ig JC et al. 2005. Glabridin, an isoflavan from licorice root, inhibits inducible nitric‐oxide synthase expression and improves survival of mice in experimental model of septic shock. J Pharmacol Exp Ther 312: 1187–1194. [DOI] [PubMed] [Google Scholar]
  117. Josephs RA, Guinn JS, Harper ML, Askari F. 2001. Liquorice consumption and salivary testosterone concentrations. Lancet 358: 1613–1614. [DOI] [PubMed] [Google Scholar]
  118. Jung JI, Lim SS, Choi HJ et al. 2006. Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells. J Nutr Biochem 17: 689–696. [DOI] [PubMed] [Google Scholar]
  119. Kamei J, Saitoh A, Asano T et al. 2005. Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo‐to (Mai‐men‐dong‐tang). Eur J Pharmacol 507: 163–168. [DOI] [PubMed] [Google Scholar]
  120. Kanazawa M, Satomi Y, Mizutani Y et al. 2003. Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol 43: 580–586. [DOI] [PubMed] [Google Scholar]
  121. Kang OH, Kim JA, Choi YA et al. 2005. Inhibition of interleukin‐8 production in the human colonic epithelial cell line HT‐29 by 18 beta‐glycyrrhetinic acid. Int J Mol Med 15: 981–985. [PubMed] [Google Scholar]
  122. Kase Y, Saitoh K, Ishige A, Komatsu Y. 1998. Mechanisms by which Hange‐Shashin to reduce prostaglandin E2 levels. Biol Pharm Bull 21: 1277–1281. [DOI] [PubMed] [Google Scholar]
  123. Kassir ZA. 1985. Endoscopic controlled trial of four drug regimens in the treatment of chronic duodenal ulceration. Ir Med J 78: 153–156. [PubMed] [Google Scholar]
  124. Kent UM, Aviram M, Rosenbalt M, Hollenberg PF. 2002. The licorice root derived isoflavin glabridin inhibits the activities of human cytochrome P450S 3A4, 2B6 and 2C9. Drug Metab Dispos 30: 709–715. [DOI] [PubMed] [Google Scholar]
  125. Kim HJ, Seo SH, Lee B‐G, Lee YS. 2005. Identification of tyrosinase inhibitors from Glycyrrhiza uralensis . Planta Med 71: 785–787. [DOI] [PubMed] [Google Scholar]
  126. Kimura M, Watanabeh H, Abo T. 1992. Selective activation of extrathymic T cells in the liver by glycyrrhizin. Biotherapy 5: 167–176. [DOI] [PubMed] [Google Scholar]
  127. Kinoshita T, Tamura Y, Mizutani K. 2005. The isolation and structure elucidation of minor isoflavonoids from licorice of Glycyrrhiza glabra origin. Chem Pharm Bull 53: 847–849. [DOI] [PubMed] [Google Scholar]
  128. Kitagawa K, Nishino N, Iwashima A. 1986. Inhibition of the specific binding of 12‐O‐tetradecanoylphorbol‐13‐acetate to mouse epidermal membrane fractions by glycyrrhetic acid. Oncology 43: 127–130. [DOI] [PubMed] [Google Scholar]
  129. Kiyohara H, Takemoto N, Zhao JH, Kawamura H, Yamada H. 1996. Pectic polysaccharides from roots of Glycyrrhiza uralensis: possible contribution of neutral oligosaccharides in the galacturonase‐resistant region to anti‐complementary and mitogenic activities. Planta Med 62: 14–19. [DOI] [PubMed] [Google Scholar]
  130. Kobayashi M, Schmitt DA, Utsunomiya T, Pollard RB, Suzuki F. 1993. Inhibition of burn‐associated suppressor cell generation by glycyrrhizin through the induction of contrasuppressor T cells. Immunol Cell Biol 71: 181–189. [DOI] [PubMed] [Google Scholar]
  131. Kobayashi S, Miyamoto T, Kimura I, Kimura M. 1995. Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro . Biol Pharm Bull 18: 1382–1386. [DOI] [PubMed] [Google Scholar]
  132. Kondo Y, Takano F. 1994. Nitric oxide production in mouse peritoneal macrophages enhanced with glycyrrhizin. Biol Pharm Bull 17: 759–761. [DOI] [PubMed] [Google Scholar]
  133. Krahenbuhl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R. 1994. Kinetics and dynamics of orally administered 18 beta‐glycyrrhetinic acid in humans. J Clin Endocrinol Metab 78: 581–585. [DOI] [PubMed] [Google Scholar]
  134. Kroes BH, Beukelman CJ, Van Den Berg AJJ, Wolbink GJ, Van Dijk H, Labadie RP. 1997. Inhibition of human complement by beta‐glycyrrhetinic acid. Immunology 90: 115–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Kuroda M, Mimaki Y, Sashida Y et al. 2003. Phenolics with PPAR‐γ ligand‐binding activity obtained from licorice (Glycyrrhiza uralensis roots) and ameliorative effects of glycyrin on genetically diabetic KK‐Ay mice. Bioorg Med Chem Lett 13: 4267–4272. [DOI] [PubMed] [Google Scholar]
  136. Latif SA, Conca TJ, Morris DJ. 1990. The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3 alpha‐ and 3 betahydroxysteroid dehydrogenases and 5 alpha‐ and 5 beta‐reductase pathways of metabolism of aldosterone in male rats. Steroids 55: 52–58. [DOI] [PubMed] [Google Scholar]
  137. Lee EB, Yun HS, Woo WS. 1977. Plants and animals used for fertility regulation in Korea. Korean J Pharmacog 8: 81–87. (From NAPRALERT) [Google Scholar]
  138. Leung YK, Ng TB, Ho JW. 2003. Transcriptional regulation of fosl‐1 by licorice in rat Clone 9 cells. Life Sci 73: 3109–3121. [DOI] [PubMed] [Google Scholar]
  139. Li JR, Wang YQ, Deng ZZ. 2005. Two new compounds from Glycyrrhiza glabra. J Asian Nat Prod Res 7: 677–680. [DOI] [PubMed] [Google Scholar]
  140. Lin CC, Lu YP, Lou YR et al. 2001. Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA‐DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice. Cancer Lett 168: 125–132. [DOI] [PubMed] [Google Scholar]
  141. Lin G, Nnane IP, Cheng TV. 1999. The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine‐induced hepatotoxicity in rats. Toxicon 37: 1259–1270. [DOI] [PubMed] [Google Scholar]
  142. Lin JC. 2003. Mechanism of action of glycyrrhizic acid in inhibition of Epstein‐Barr virus replication in vitro . Antiviral Res 59: 41–47. [DOI] [PubMed] [Google Scholar]
  143. Luper S. 1999. A review of plants used in the treatment of liver disease: Part Two. Altern Med Rev 4: 178–188. [PubMed] [Google Scholar]
  144. Ma J, Fu NY, Pang DB, Wu WY, Xu AL. 2001. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC‐803 cells. Planta Med 67: 754–757. [DOI] [PubMed] [Google Scholar]
  145. MacKenzie MA, Hoefnagels WH, Kloppenborg PW. 1990. Glycyrrhetinic acid and potentiation of hydrocortisone activity in skin. Lancet 335: 1534. [DOI] [PubMed] [Google Scholar]
  146. Maggiolini M, Statti G, Vivacqua A et al. 2002. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J Steroid Biochem Mol Biol 82: 315–322. [DOI] [PubMed] [Google Scholar]
  147. Matchkov VV, Rahman A, Peng H, Nilsson H, Aalkjaer C. 2004. Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteries. Br J Pharmacol 142: 961–972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Mendes‐Silva W, Assafim M, Ruta B, Monteiro RQ, Guimaraes JA, Zingali RB. 2003. Antithrombotic effect of glycyrrhizin, a plant‐derived thrombin inhibitor. Thrombosis Res 112: 93–98. [DOI] [PubMed] [Google Scholar]
  149. Miyakawa Y, Iino S. 2001. Toward prevention of hepatocellular carcinoma developing in chronic hepatitis C. J Gastroenterol Hepatol 16: 711–714. [DOI] [PubMed] [Google Scholar]
  150. Mizuhara Y, Takizawa Y, Ishihara K et al. 2005. The influence of the sennosides on absorption of glycyrrhetic acid in rats. Biol Pharm Bull 28: 1897–1902. [DOI] [PubMed] [Google Scholar]
  151. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CR. 1989. Licorice inhibits corticosteroid 11β‐dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 125: 1046–1053. [DOI] [PubMed] [Google Scholar]
  152. Moon A, Kim SH. 1996. Effect of Glycyrrhiza glabra roots and glycyrrizin on the glucoronidation in rats. Planta Med 62: 115–119. [DOI] [PubMed] [Google Scholar]
  153. Mu Y, Zhang J, Zhang S et al. 2006. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate PXR and increase warfarin clearance in rats. J Pharmacol Exp Ther 316: 1369–1377. [DOI] [PubMed] [Google Scholar]
  154. Nacagiri R, Oda H, Kamiya T. 2003. Small scale rat hepatocyte primary culture with applications for screening hepatoprotective substances. Biosci Biotechnol Biochem 67: 1629–1635. [DOI] [PubMed] [Google Scholar]
  155. Näf R, Jaquier A. 2006. New lactones in liquorice (Glycyrrhiza glabra L.). Flavour Fragr J 21: 193–197. [Google Scholar]
  156. Nagai T, Egashira T, Yamanaka Y, Kohno M. 1991. The protective effect of glycyrrhizin against injury of the liver caused by ischemia‐reperfusion. Arch Environ Contam Toxicol 20: 432–436. [DOI] [PubMed] [Google Scholar]
  157. Nakajima N, Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. 1996. In vitro induction of anti‐type 2 T cells by glycyrrhizin. Burns 22: 612–617. [DOI] [PubMed] [Google Scholar]
  158. Nakamura T, Fujii T, Ichihara A. 1985. Enzyme leakage due to change of membrane permeability of primary cultured rat hepatocytes treated with various hepatotoxins and its prevention by glycyrrhizin. Cell Biol Toxicol 1: 285–295. [DOI] [PubMed] [Google Scholar]
  159. Nielsen I, Pedersen RS. 1984. Life‐threatening hypokalaemia caused by liquorice ingestion. Lancet 1: 1305. [DOI] [PubMed] [Google Scholar]
  160. Nishioka, K, Seguchi T. 1999. Contact allergy due to oil soluble licorice extracts in cosmetics products. Contact Dermatitis 40: 56. [DOI] [PubMed] [Google Scholar]
  161. Nisteswar K, Murthy VK. 1989. Aphrodisiac effect of indigenous drugs – a myth or reality? Probe 28: 89–92. (From NAPRALERT) [Google Scholar]
  162. Nomura1 T, Fukai1 T, Akiyama T. 2002. Chemistry of phenolic compounds of licorice (Glycyrrhiza species) and their estrogenic and cytotoxic activities. Pure Appl Chem 74: 1199–1206. [Google Scholar]
  163. Nose M, Ito M, Kamimura K, Shimizu M, Ogihara Y. 1994. A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid. Planta Med 60: 136–139. [DOI] [PubMed] [Google Scholar]
  164. Nose M, Terawaki K, Oguri K, Ogihara Y, Yoshimatsu K, Shimomura K. 1998. Activation of macrophages by crude polysaccharide fractions obtained from shoots of Glycyrrhiza glabra and hairy roots of Glycyrrhiza uralensis. Biol Pharm Bull 21: 1110–1112. [DOI] [PubMed] [Google Scholar]
  165. Numazaki K, Umetsu M, Chiba S. 1994. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection. Tohoku J Exp Med 172: 147–153. [DOI] [PubMed] [Google Scholar]
  166. Ody P. 2000. The Complete Guide Medicinal Herbal. Dorling Kindersley: London, 75. [Google Scholar]
  167. Ofir R, Tamir S, Khatib S, Vaya J. 2003. Inhibition of serotonin re‐uptake by licorice constituents. J Mol Neurosci 20: 135–140. [DOI] [PubMed] [Google Scholar]
  168. Oganisyan AO, Oganesyan KR, Minasyan SM. 2005. Changes in succinate dehydrogenase activity in various parts of the brain during combined exposure to vibration and licorice root. Neurosci Behav Physiol 35: 545–548. [DOI] [PubMed] [Google Scholar]
  169. Ohuchi K, Kamada Y, Levine L, Tsurufuji S. 1981. Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostagland Med 7: 457. [DOI] [PubMed] [Google Scholar]
  170. Okuno M, Kojima S, Moriwaki H. 2001. Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives. J Gastroenterol Hepatol 16: 1329–1335. [DOI] [PubMed] [Google Scholar]
  171. Olukoga A, Donaldson D. 2000. Liquorice and its health implications. J R Soc Health 120: 83–89. [DOI] [PubMed] [Google Scholar]
  172. Onkarappa R, Shobha KS, Chaya K. 2005. Efficacy of four medicinally important plant extracts (crude) against pathogenic bacteria. Asian J Microbiol Biotech Env Sci 7: 281–284. [Google Scholar]
  173. Palermo M, Quinkler M, Stewart PM. 2004. Apparent mineralocorticoid excess syndrome: an overview. Arq Bras Endocrinol Metab 48: 687–696. [DOI] [PubMed] [Google Scholar]
  174. Paolini M, Pozzeti L, Sapone A, Cantelli‐Forti G. 1998. Effect of licorice and glycyrrhizin on murine liver CYP‐dependent monooxygenases. Life Sci 62: 571–582. [DOI] [PubMed] [Google Scholar]
  175. Perera P, Ringbom T, Huss U, Vasange M, Bohlin L. 2001. Search for natural products which affect cyclooxygenase‐2 In Bioactive Compounds from Natural Sources: Isolation, Characterization and Biological Properties, Tringali C. (ed.). Taylor and Francis: New York, 458, 462. [Google Scholar]
  176. Petit L, Pierard E. 2003. Skin‐lightening products revisited. Int J Cosm Sci 25: 109–181. [DOI] [PubMed] [Google Scholar]
  177. Piamphongsant T. 1998. Treatment of melasma: a review with personal experience. Int J Dermtol 37: 897–903. [DOI] [PubMed] [Google Scholar]
  178. Pompei R, Flore O, Marccialis MA, Pani A, Loddo B. 1979. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 281: 689–690. [DOI] [PubMed] [Google Scholar]
  179. Puodziuniene G, Janulis V, Milasius A, Budnikas V. 2005. Development of cough‐relieving herbal teas. Medicina 41: 500–505. [PubMed] [Google Scholar]
  180. Radhakrishnan N, Phil M, Gnanamani A, Sadulla S. 2005. Effect of licorice (Glycyhrriza glabra Linn.), a skin‐whitening agent on Black molly (Poecilia latipinnaa). J Appl Cosm 23: 149–158. [Google Scholar]
  181. Rafi MM, Rosen RT, Vassil A et al. 2000. Modulation of bcl‐2 and cytotoxicity by licochalcone‐A, a novel estrogenic flavonoid. Anticancer Res 20: 2653–2658. [PubMed] [Google Scholar]
  182. Rafi MM, Vastano BC, Zhu N et al. 2002. Novel polyphenol molecule isolated from licorice root (Glycyrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl‐2 phosphorylation in tumor cell lines. J Agric Food Chem 50: 677–684. [DOI] [PubMed] [Google Scholar]
  183. Rajurkar NS, Pardeshi BM. 1997. Analysis of some herbal plants from India used in the control of mellitus by NAA and AAS techniques. Appl Radiat Isot 48: 1059–1062. [DOI] [PubMed] [Google Scholar]
  184. Raphael TJ, Kuttan G. 2003. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine 10: 483–489. [DOI] [PubMed] [Google Scholar]
  185. Rosenblat M, Belinky P, Vaya J et al. 1999. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase‐induced cell‐mediated oxidation of low density lipoprotein: a possible role for protein kinase C. J Biol Chem 274: 13790–13799. [DOI] [PubMed] [Google Scholar]
  186. Rosenblat M, Coleman R, Aviram M. 2002. Increased macrophage glutathione content reduces cell‐mediated oxidation of LDL and atherosclerosis in apolipoprotein E‐deficient mice. Atherosclerosis 163: 17–28. [DOI] [PubMed] [Google Scholar]
  187. Rossi T, Benassi L, Magnoni C, Ruberto AI, Coppi A, Baggio G. 2005. Effects of glycyrrhizin on UVB‐irradiated melanoma cells. In Vivo 19: 319–322. [PubMed] [Google Scholar]
  188. Sabahi M, Mansouri SH, Ramezanian M, Gholam‐Hoseinian A. 1987. Screening of plants from the southeast of Iran for antimicrobial. Int J Crude Drug Res 25: 72–76. [Google Scholar]
  189. Saeedi M, Morteza‐Semnani K, Ghoreishi MR. 2003. The treatment of atopic dermatitis with licorice gel. J Dermatol Treat 14: 153–157. [DOI] [PubMed] [Google Scholar]
  190. Sakamoto K, Wakabayashi K. 1988. Inhibitory effect of glycyrrhetinic acid on testosterone production in rat gonads. Endocrinol Jpn 35: 333–342. [DOI] [PubMed] [Google Scholar]
  191. Salvi M, Fiore C, Armanini D, Toninello A. 2003. Glycyrrhetinic acid‐induced permeability transition in rat liver mitochondria. Biochem Pharmacol 66: 2375–2379. [DOI] [PubMed] [Google Scholar]
  192. Santicioli P, Maggi CA. 2000. Effect of 18 beta‐glycyrrhetinic acid on electromechanical coupling in the guinea‐pig renal pelvis and ureter. Br J Pharmacol 129: 163–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Santoro NF, Clarkson TB, Freedman RR, Fugh‐Berman AJ, Loprinzi CL, Reame NK. 2004. Treatment of menopause‐associated vasomotor symptoms: position statement of menopause. Menopause 11: 11–33. [DOI] [PubMed] [Google Scholar]
  194. Sato H, Goto W, Yamamura J et al. 1996. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res 30: 171–177. [DOI] [PubMed] [Google Scholar]
  195. Schleimer RP. 1991. Potential regulation of inflammation in the lung by local metabolism of hydrocortisone. Am J Respir Cell Mol Biol 4: 166–173. [DOI] [PubMed] [Google Scholar]
  196. Scully C, Gorsky M, Lozado‐Nur F. 2002. Aphthus ulcerations. Dermatol Ther 15: 185–205. [Google Scholar]
  197. Sheela ML, Ramakrishna MK, Salimath BP. 2006. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra . Int Immunopharmacol 6: 494–498. [DOI] [PubMed] [Google Scholar]
  198. Shibata S. 2000. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120: 849–862. [DOI] [PubMed] [Google Scholar]
  199. Shibata S, Inoue H, Iwata S et al. 1991. Inhibitory effects of lichochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumor promotion in mice. Planta Med 51: 221–224. [DOI] [PubMed] [Google Scholar]
  200. Shiki Y, Shirai K, Saito Y, Yoshida S, Mori Y, Wakashin M. 1992. Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti‐liver cell membrane antibody. J Gasteroenterol Hepatol 7: 12–16. [DOI] [PubMed] [Google Scholar]
  201. Shintani S, Murase H, Tsukagoshi H, Shiigai T. 1992. Glycyrrhizin (licorice)‐induced hypokalemic myopathy: report of 2 cases and review of the literature. Eur Neurol 32: 44–51. [DOI] [PubMed] [Google Scholar]
  202. Sircar NN. 1984. Pharmaco‐therapeutics of dasemani drugs. Ancient Sci Life 3: 132–135. (From NAPRALERT) [PMC free article] [PubMed] [Google Scholar]
  203. Smith WP. 1999. The effects of topical L (+) lactic acid and ascorbic acid on skin whitening. Int J Cosmet Sci 21: 33–40. [DOI] [PubMed] [Google Scholar]
  204. Sohn EJ, Kang DJ, Lee HS. 2003. Protective effects of glycyrrhizin on gentamicin‐induced acute renal failure in rats. Pharm Toxicol 93: 116–122. [DOI] [PubMed] [Google Scholar]
  205. Somjen D, Katzburg S, Vaya J et al. 2004a. Estrogenic activity of glabridin and glabrene from licorice roots on human osteoblasts and prepubertal rat skeletal tissues. J Steroid Biochem Mol Biol 91: 241–246. [DOI] [PubMed] [Google Scholar]
  206. Somjen D, Knoll E, Vaya J, Stern N, Tamir S. 2004b. Estrogen‐like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo . J Steroid Biochem Mol Biol 91: 147–155. [DOI] [PubMed] [Google Scholar]
  207. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CR. 1990. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta‐hydroxysteroid dehydrogenase activity in man. Clin Sci 78: 49–54. [DOI] [PubMed] [Google Scholar]
  208. Strandberg TE, Jarvenpaa AL, Vanhanen H, McKeigue PM. 2001. Birth outcome in relation to licorice consumption during pregnancy. Am J Epidemiol 153: 1085–1088. [DOI] [PubMed] [Google Scholar]
  209. Sun HX, Pan HJ. 2006. Immunological adjuvant effect of Glycyrrhiza uralensis saponins on the immune responses to ovalbumin in mice. Vaccine 24: 1914–1920. [DOI] [PubMed] [Google Scholar]
  210. Suzuki H, Nakano N, Ito M et al. 1983. Effects of glycyrrhizin and glycyrrhetinic acid on production of O2 −, H2O2 by macrophages. Igakuno Ayumi 124: 109–111. [Google Scholar]
  211. Sweetman SC. 2005. Martindale: The Complete Drug Reference. Pharmaceutical Press: London, 1254–1255, 1264. [Google Scholar]
  212. Takahara T, Watanabe A, Shiraki K. 1994. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study. J Hepatol 21: 601–609. [DOI] [PubMed] [Google Scholar]
  213. Takahashi T, Takasuka N, Iigo M et al. 2004. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 95: 448–453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Tamir S, Eizenberg M, Somjen D et al. 2000. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res 60: 5704–5709. [PubMed] [Google Scholar]
  215. Tamir S, Eizenberg M, Somjen D, Izrael S, Vaya J. 2001. Estrogen‐like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol 78: 291–298. [DOI] [PubMed] [Google Scholar]
  216. Tawata M, Aida K, Noguchi T et al. 1992. Anti‐platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol 212: 87–92. [DOI] [PubMed] [Google Scholar]
  217. Teelucksingh S, Mackie AD, Burt D, McIntyre MA, Brett L, Edwards CR. 1990. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 335: 1060–1063. [DOI] [PubMed] [Google Scholar]
  218. Tokiwa T, Harada K, Matsumura T, Tukiyama T. 2004. Oriental medicinal herb, Periploca sepium, extract inhibits growth and IL‐6 production of human synovial fibroblast‐like cells. Pharm Bull 27: 1691–1693. [DOI] [PubMed] [Google Scholar]
  219. Tsai TH, Liao JF, Shum AY, Chen CF. 1992. Pharmacokinetics of glycyrrhizin after intravenous administration to rats. J Pharm Sci 81: 961–963. [DOI] [PubMed] [Google Scholar]
  220. Tsukahara M, Nishino T, Furuhashi I, Inoue H, Sato T, Matsumoto H. 2005. Synthesis and inhibitory effect of novel glycyrrhetinic acid derivatives on IL‐1b‐induced prostaglandin E2 production in normal human dermal fibroblasts. Chem Pharm Bull 53: 1103–1110. [DOI] [PubMed] [Google Scholar]
  221. Tsukamoto S, Aburatani M, Yoshida T, Yamashita Y, El‐Beih AA, Ohta T. 2005. CYP3A4 inhibitors isolated from licorice. Biol Pharm Bull 28: 2000–2002. [DOI] [PubMed] [Google Scholar]
  222. Tyler VE, Bradly LR, Robbers JE. 1988. Pharmacognosy, 9th edn. Lea and Febiger: Philadelphia, PA, 68–69. [Google Scholar]
  223. Utsunomiya T, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. 1995. Glycyrrhizin (20b‐carboxy‐11‐oxo‐30‐norolean‐ 12‐en‐3b‐yl‐2‐O‐b‐D‐glucopyranuronosyl‐a‐d‐glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1. Immunol Lett 44: 59–66. [DOI] [PubMed] [Google Scholar]
  224. Utsunomiya T, Kobayashi M, Ito M, Pollard RB, Suzuki F. 2000. Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS‐associated Type 2 T Cell responses. Clin Immunol 95: 145–155. [DOI] [PubMed] [Google Scholar]
  225. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. 1997. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother 41: 551–556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Van Den Bosch AE, Van der Klooster JM, Zuidgeest DMH, Ouwendijk RJTh, Dees A. 2005. Severe hypokalaemic paralysis and rhabdomyolysis due to ingestion of liquorice. Neth J Med 63: 146–148. [PubMed] [Google Scholar]
  227. Van Marle J, Aarsen PN, Lind A, Van Weeren‐Kramer J. 1981. Deglycyrrhizinised liquorice (DGL) and the renewal of rat stomach epithelium. Eur J Pharmacol 72: 219–225. [DOI] [PubMed] [Google Scholar]
  228. Van Rossum TGJ, Vulto AG, De Man RA, Brouwer JT, Schalam SW. 1998. Review article: Glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 12: 199–205. [DOI] [PubMed] [Google Scholar]
  229. Van Rossum TGJ, Vulto AG, Hop WCJ, Brouwer JT, Niesters HGM, Schalm SW. 1999. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double‐blind, randomized, placebo‐controlled phase I/II trial. J Gastroenterol Hepatol 14: 1093–1099. [DOI] [PubMed] [Google Scholar]
  230. Van Uum SH. 2005. Liquorice and hypertension. Neth J Med 63: 119–120. [PubMed] [Google Scholar]
  231. Varshney IP, Jain DC, Srivastava HC. 1983. Study of saponins from Glycyrrhiza glabra root. Int J Crude Drug Res 21: 169–172. (From NAPRALERT) [Google Scholar]
  232. Vaya J, Belinky PA, Aviram M. 1997. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med 23: 302–313. [DOI] [PubMed] [Google Scholar]
  233. Walker BR, Edwards CR. 1991. 11 beta‐Hydroxysteroid dehydrogenase and enzyme‐mediated receptor protection: life after liquorice? Clin Endocrinol 35: 281–289. [DOI] [PubMed] [Google Scholar]
  234. Wang ZY, Nixon DW. 2001. Licorice and cancer. Nutr Cancer 39: 1–11. [DOI] [PubMed] [Google Scholar]
  235. Wang Z, Okamoto M, Kurosaki Y, Nakayama T, Kimura T. 1996. Pharmacokinetics of glycyrrhizin in rats with d‐galactosamine‐induced hepatic disease Biol Pharm Bull 19: 901–904. [DOI] [PubMed] [Google Scholar]
  236. Williamson EM. 2003. Liquorice In Potter's Cyclopedia of Herbal Medicines. C W Daniels: Saffron Walden, UK, 269–271. [Google Scholar]
  237. Yaginuma T, Izumi R, Yasui H, Arai T, Kawabata M. 1982. Effect of traditional herbal medicine on serum testosterone levels and its induction of regular ovulation in hyperandrogenic and oligomenorrheic women. Nippon Sanka Fujinka Gakkai Zhasshi 34: 939–944. [PubMed] [Google Scholar]
  238. Yamada H, Kiyohara H, Takemoto N et al. 1992. Mitogenic and complement activating activities of the herbal component of Juzen‐Taiho‐To. Planta Med 58: 166–170. [DOI] [PubMed] [Google Scholar]
  239. Yamamoto S, Aizu E, Jiang H et al. 1991. The potent antitumor‐promoting agent isoliquiritigenin. Carcinogenesis 12: 317–323. [DOI] [PubMed] [Google Scholar]
  240. Yamamoto Y, Fukuta H, Nakahira Y, Suzuki H. 1998. Blockade by 18β‐glycyrrhetinic acid of intercellular electrical coupling in guinea‐pig arterioles. J Physiol 511: 501–508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Yamazaki S, Morita T, Endo H et al. 2002. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett 183: 23–30. [DOI] [PubMed] [Google Scholar]
  242. Yarnell E. 1997. Botanical medicine for cystitis. Altern Complement Ther 3: 269–275. (From NAPRALERT) [Google Scholar]
  243. Yokota T, Nishio H, Kubota Y, Mizoguchi M. 1998. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 11: 355–61. [DOI] [PubMed] [Google Scholar]
  244. Yokozawa T, Cho EJ, Rhyu DY, Shibahara N, Aoyagi K. 2005. Glycyrrhizae Radix attenuates peroxynitrite‐induced renal oxidative damage through inhibition of protein nitration. Free Radic Res 39: 203–211. [DOI] [PubMed] [Google Scholar]
  245. Yoon G, Jung YD, Cheon SH. 2005. Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflate . Chem Pharm Bull 53: 694–695. [DOI] [PubMed] [Google Scholar]
  246. Yu SM, Kuo SC. 1995. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. Br J Pharmacol 114: 1587–1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Yu Z, Ohtaki Y, Kaid K et al. 2005. Critical roles of platelets in lipopolysaccharide‐induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome. Int Immunopharmacol 5: 571–580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Zakirov NU, Aizimov MI, Kurmukov AG. 1999. The cardioprotective action of 18‐dehydroglycyrrhetic acid in experimental myocardial damage. Eksp Klin Farmakol 62: 19–21. [PubMed] [Google Scholar]
  249. Zhai L, Blom J, Chen M, Christensen SB, Kharazmi A. 1995. The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria. Antimicrob Agents Chemother 39: 2742–2748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Zhan C, Yang J. 2006. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion‐induced focal cerebral ischemia in rats. Pharm Res 53: 303–309. [DOI] [PubMed] [Google Scholar]
  251. Zhang YH, Isobe K, Nagase F et al. 1993. Glycyrrhizin as a promoter of the late signal transduction of interleukin‐2 production by splenic lymhocytes. Immunology 79: 528–534. [PMC free article] [PubMed] [Google Scholar]
  252. Zhang L, Wang B. 2002. Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo‐Minophagen C in Chinese patients with chronic hepatitis B. Hepatol Res 24: 220. [DOI] [PubMed] [Google Scholar]
  253. Zhao JF, Kioyahara H, Yamada H, Takemoto N, Kawamura H. 1991. Heterogeneity and characterisation of mitogenic and anti‐complementary pectic polysaccharides from the roots of Glycyrrhiza uralensis Fisch et D.C. Carbohydr Res 219: 149–172. [DOI] [PubMed] [Google Scholar]

Articles from Phytotherapy Research are provided here courtesy of Wiley

RESOURCES